Updates in advances in lung cancer:

Lung cancer remains a major cause of cancer deaths throughout the world. It is an extremely lethal neoplasm: 80–90% of patients who develop lung cancer will die of their disease.The purpose of this book is to update cancer specialists, pulmonary physicians, thoracic surgeons and general practitioner...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: Schiller, Joan H. (HerausgeberIn)
Format: Elektronisch E-Book
Sprache:English
Veröffentlicht: Basel Karger 1997
Schriftenreihe:Progress in respiratory research Vol. 29
Schlagworte:
Online-Zugang:BFB01
BSB01
BTW01
EUV01
FAN01
FAW01
FFW01
FHI01
FHM01
FHN01
FHR01
FKE01
FNU01
FWS01
FWS02
GEM01
LCO01
SAB01
SAM01
SBG01
SBR01
SND01
TUM01
UBA01
UBG01
UBM01
UBR01
UBT01
UBW01
UER01
UPA01
Volltext
Zusammenfassung:Lung cancer remains a major cause of cancer deaths throughout the world. It is an extremely lethal neoplasm: 80–90% of patients who develop lung cancer will die of their disease.The purpose of this book is to update cancer specialists, pulmonary physicians, thoracic surgeons and general practitioners about the many recent advances in the treatment, prevention and biology of lung cancer. Despite the overall poor prognosis for patients, a number of new chemotherapeutic drugs and regimens have been developed which result in a clinically meaningful improvement in survival for patients with nonsmall cell lung carcinoma. Four chapters in this book are devoted to reviewing these new drugs and drug combinations (paclitaxel, docetaxel, vinorelbine, gemcitabine, topoisomerase inhibitors). Advances in the management of locally advanced nonsmall cell and small cell lung cancer are considered, including combined-modality treatments using chemotherapy, surgery, and radiation therapy. Results of recent trials involving chemoprevention agents are also reported. Finally, the latest progress in understanding the molecular biology of this disease, and how it might impact on the clinical management of lung cancer patients, is discussed
Beschreibung:evaluating new chemotherapeutic regimens for treatment and prevention
Beschreibung:1 Online-Ressource (X, 192 Seiten) Diagramme
ISBN:9783318002546